 | Up a level |
Baur, R; Gertsch, J; Sigel, E (2012). The cannabinoid CB1 receptor antagonists rimonabant (SR141716) and AM251 directly potentiate GABA(A) receptors. British journal of pharmacology, 165(8), pp. 2479-84. Oxford: Wiley-Blackwell 10.1111/j.1476-5381.2011.01405.x
Chicca, A; Marazzi, J; Gertsch, J (2012). The antinociceptive triterpene β-amyrin inhibits 2-arachidonoylglycerol (2-AG) hydrolysis without directly targeting cannabinoid receptors. British journal of pharmacology, 167(8), pp. 1596-608. Oxford: Wiley-Blackwell 10.1111/j.1476-5381.2012.02059.x
Ritchie, M R; Gertsch, J; Klein, P; Schoop, R (2011). Effects of Echinaforce® treatment on ex vivo-stimulated blood cells. Phytomedicine, 18(10), pp. 826-31. Amsterdam: Elsevier 10.1016/j.phymed.2011.05.011
Gollner, A; Altmann, K.-H; Gertsch, J; Mulzer, J (2009). Synthesis and biological evaluation of a des-dihydropyran laulimalide analog. Tetrahedron letters, 50(42), pp. 5790-5792. Amsterdam: Elsevier 10.1016/j.tetlet.2009.07.122
Modarai, M; Gertsch, J; Suter, A; Heinrich, M; Kortenkamp, A (2007). Cytochrome P450 inhibitory action of Echinacea preparations differs widely and co-varies with alkylamide content. Journal of pharmacy and pharmacology, 59(4), pp. 567-73. London: Royal Pharmaceutical Society of Great Britain 10.1211/jpp.59.4.0012
Gertsch, J; Anavi-Goffer, S (2012). Methylhonokiol attenuates neuroinflammation: a role for cannabinoid receptors? 9. J Neuroinflammation 10.1186/1742-2094-9-135
